Live Agent
Questions About Lasik or Cataract Surgery?
Talk to a LIVE Agent!
Monday - Friday: 7:30AM - 9:00 PM
Saturday - Sunday: 11:00 - 5:00 PM
In conceptualizing the perfect LASIK and Cataract clinic in Fort Worth, TX, Dr. Brett Mueller aspired to create an establishment that mirrored the communal essence of Fort Worth itself.
For Dr. Mueller, the ethos of such a place is encapsulated in the notion of treating people like FAMILY. He acknowledges the profound impact of eye surgery, considering it among the top life-altering experiences as it liberates individuals from the dependence on corrective lenses, offering them the vision they’ve longed for through various advanced procedures such as Modern LASIK, EVO ICL, SMILE LASIK, PRK, Custom Lens Replacement, or Laser Cataract Surgery.
Dr. Mueller, a 6th generation Texan, approaches his practice with a deep-seated belief in treating patients as if they were members of his own family, ensuring they are valued, their concerns are heard, and their outcomes are exceptional. His commitment extends to delivering personalized care, leveraging his expertise in all seven vision correction methodologies to tailor each procedure to the unique needs of the patient’s eyes, thereby maximizing the potential for optimal results.
Specializing in
- Laser Cataract Surgery
- LASIK Eye Surgery
- Personalized, Tpographically – Guided LASIK
- EVO ICL Surgery
- SMILE LASIK
- Refractive Lens Exchange
- PRK
- Cross-Linking
- Surgical Co-Management
- Minimally Invasive Glaucoma Surgery
- Standard Cataract Surgery
- Pterygium Surgery
Committed to Excellence and Advancing the Field of LASIK & Cataract Eye Surgery
Dr. Brett Mueller is an esteemed board-certified and fellowship-trained ophthalmologist, renowned for his expertise in LASIK and cataract eye surgery. His extensive training includes a fellowship with the prestigious World College of Refractive Surgery and Visual Sciences and the Refractive Surgery Alliance Fellowship Network.
This advanced education has equipped him with a vast skill set to address the entire gamut of vision correction procedures. Embodying the spirit of Texas, Dr. Mueller is delighted to serve the Dallas/Fort Worth area as founder of Mueller Vision, delivering top-tier surgical and laser solutions to enhance your vision.
Educationally, Dr. Mueller’s journey commenced at Texas A&M, majoring in Biomedical Science, followed by his medical and doctoral education at the University of North Texas Health Science Center. His doctoral research delved into innovative treatments within Ophthalmology, establishing his reputation with over 60 scholarly publications presented globally.
Dr. Mueller’s roles have included principal and sub-investigator on many industry and FDA clinical trials, illustrating his dedication to advancing ophthalmology and vision correction surgery. His commitment to the evolution of his field promises continued advancements for his patients’ benefit for years ahead.
Open Letter to Patients
I remember distinctly the exact time when I knew that I wanted to be an ophthalmologist. It was June 2007, and I had just completed a ten-day medical mission trip to Guatemala, where we served over 2000 patients. These patients came to our clinic seeking something very foreign to them: medical care. I recall one elderly man, blinded by cataracts, who took the arduous journey of over eight hours from the Guatemalan hills, with his grandson holding his hand, guiding each step. Upon entering the patient room with the general surgeon, we had to apologize to this elderly man and his grandson, because there was no ophthalmologist at the facility, so we could not remove his cataracts. As the look of joyous hope turned to despairing sadness, the grandfather communicated through tear-filled eyes that all he wanted to do was to see the sunrise one last time, behold the beauty of nature, and look into the eyes of his grandson. As they left, I felt an overwhelming sense of compassion, as I would have given anything to have been able to help him that day.
This story resonates with me, because I see this elderly man in every single one of the patients that I treat on a daily basis. Whether it be people who come in that are not able to experience life to their fullest because of their cataracts, or blinded because of their near-sightedness or astigmatism. I love being able to offer solutions to YOU for these conditions, and see that look of joy come across your face when you discover that there is a cure, that you can live life with clear, crisp vision.
These moments are even more special to me when I get to provide them for my family. My mother just recently had laser cataract surgery, and can now see 20/15 at distance, and read her book without the need of reading glasses. She describes her vision as like how it was when she was 20 years old. My sister, who was blinded by her nearsightedness since she was 3 just recently had EVO ICL procedure performed on her, and she can now see 20/10 without the aid of glasses or contacts and describes everything in her world being in HD. These stories happen all the time with my patients, and I feel very blessed and fortunate to be able to share these moments with you.
As a LASIK and cataract eye surgeon, I daily witness patients and family members frustrated by loss of eyesight due to cataracts, or the debilitation from needing to be dependent upon prosthetic eyewear. Such experiences always bring me back to my experiences in Guatemala, but now, instead of telling this grandfather and grandson that there is nothing we can do, I can now say, “There is something that I can do … I can help you.”
Sincerely,
Dr. Brett Mueller
Affiliations
Dr. Mueller holds board certification from the American Board of Ophthalmology and is distinguished as the inaugural LASIK eye surgeon globally to complete a two-year fellowship at the World College of Refractive Surgery and Visual Sciences.
Dr. Mueller is multi-faceted, taking on the roles of surgeon, educator, lecturer, and researcher with equal passion. He remains a leading figure in refractive surgery, committed to advancing eye surgery techniques to benefit patients globally. Dr. Mueller is multi-faceted, taking on the roles of surgeon, educator, lecturer, and researcher with equal passion. He remains a leading figure in refractive surgery, committed to advancing eye surgery techniques to benefit patients globally.
Education & Experience
Nationally Recognized Surgeon, Leader, Educator, & researcher
Undergraduate/Medical School/Residency:
- Texas A&M University
- Medical School and Graduate School (PhD): University of North Texas Health & Science Center
- Residency Training in Eye Surgery: University of Louisville, selected to be Chief Resident
Fellowship:
- World College of Refractive Surgery & Visual Science, Refractive Surgery Alliance Fellowship Network, & Parkhurst NuVision LASIK Eye Surgery
Physician CEO/Other Affiliations:
- Kellogg School of Management at Northwestern University
- Associated Academic Director for the Refractive Surgery Alliance Fellowship Network
- STAAR Surgeon EVO ICL National Trainer
- Adjunct Assistant Professor at the University of North Texas Health Science Center
Mueller Vision Gives Back to the Community Both Locally and Globally
At Mueller Vision, there is a profound recognition of a calling that transcends individual interests. It is with immense honor and a sense of privilege that the team, led by Dr. Mueller, extends the precious gift of sight to numerous individuals. Central to their mission is a commitment to the global fight against blindness.
Dr. Mueller’s efforts are not confined to his local community, where he aids low-income individuals with cataract surgeries, but also span across international borders where he performs similar surgeries in developing countries.
Collaboration with the Himalayan Cataract Project (HCP) is a testament to their dedication, wherein Mueller Vision contributes a portion of each elective surgery’s cost towards funding cataract surgeries in underserved regions worldwide. This initiative is a clear reflection of how Mueller Vision is incorporating the Fort Worth community to aid in the fight against global blindness.
Achievements
- Recognized as one of the Best Cataract Surgeons and Best LASIK Surgeons in America (2024)
- Recognized as being a Top Doctor (2024)
- Best in Texas Magazine Doctors (2024)
- Recognized as a One to Watch Eye Surgeon in the United States. Award to the top eye surgeons in the country (2023)
- Top Doctors in Ophthalmology: Castly Connolly Rising Star (2022 – 2023)
- AECOS/Cedars Aspens Mentorship Forum (2021)
- Dr. Melvyn Koby Educational Excellence Award – Award to the top eye surgeon at the University of Louisville (2018)
- Heed Resident Retreat Attendee – Awarded to the top residents in the country on the basis of academic achievement (2016)
- University of North Texas Health Science Center Chancellor’s Award – Awarded to the top graduate for research accomplishments at UNTHSC amongst all the students graduating in the medical school, graduate school, school of public health, and school of health professions. (2014)
- University of North Texas Health Science Center Graduate Student of the Year Award – Awarded to the top graduate student at UNTHSC. (2014)
Research/Publications/Presentations
Dr. Mueller has contributed substantially to the field of Ophthalmology
Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78. doi: 10.2147/OPTH.S440578. PMID: 38223817; PMCID: PMC10787571.
Drew Dickson, MD, Matthew Pagano, BS, MS, Brett Mueller, DO, PhD; Lance J. Kugler, MD. Lost in Translation: The Power of Precision in Refractive Surgery Medical Terminology. YoungMD>Connect. October 4, 2023
Neda Nikpoor, MD; Arjan Hura, MD; Brett Mueller, DO, PhD; Brian Shafer, MD; & Dagny Zhu, MD. Variable Measurements. Cataract Surgery. CRST. October 2023
Brett Mueller, MD & Lauren Libfraind, MD. Refractive Surgery Alliance Issues Updated Nomenclature Recommendations. Ophthalmology Advisor. July 10, 2023
Michael Gordon, MD; Eva Kim, MD; Brett Mueller, DO, PhD; Neda Nikapoor, MD; Stephen Wexler, MD; and Dagny Zhu, MD. How the Wavelight Refractive Suite Brings Value to Your Surgical Practice. Healio | Ocular Surgery. July 2023
Brett Mueller D.O., Ph.D., One to Watch. YoungMD>Connect. March 16, 2023
Jose F Alfonso, Ashley Brissette, Arjan Hura, Shamik Bafna, Florian Kretz, and Brett Mueller. Talking to Patients About Specific Refractive Goals. Cataract and Refractive Surgery Today. July 2022
Saenz B, Ferguson TJ, Abraham N, Mueller BH, Parkhurst GD. Evaluation of Same-Day versus Next-Day Implantation of Intracanalicular Dexamethasone for the Control of Postoperative Inflammation and Pain Following Cataract Surgery. Clin Ophthalmol. 2021 Dec 7;15:4615-4620. doi: 10.2147/OPTH.S334297. PMID: 34916773; PMCID: PMC8669496.
Mueller B. Very High-Frequency Ultrasound Improves ICL Sizing Precision. OphthalmologyTimes.com, pages 30-31, December 2021
Mueller B. Video: ArcScan a ‘game changer’ for ICL sizing. Healio News, December 6, 2021
Mueller B. The Need for More Refractive Surgeons and Refractive Surgery Fellowships. MillennialEye. 2020 January/February.
Saenz B & Mueller B. Scleral Lenses or CXL: Which Should Come First? The answer is…it depends. Modern Optometry. 2020 January/February.
Saenz B, Mueller B, Vanrachack A, Davies B. Thyroid Eye Disease in Your Exam Lane. Review of Optometry. 2019 October.
Hadayer A, Mueller B, Adeniran J, Barr C. Outcomes of Surgically Managed Proliferative Diabetic Retinopathy. Journal of VitreoRetinal Diseases. 2018 November; 2(6):338-342.
Puri S, Duff SM, Mueller B, Prendes M, Clark J. Hairpulling causing vision loss: a case report. Orbit. 2018 May 4:1-4. PubMed PMID: 29727255.
Mugavin M, Mueller BH 2nd, Desai M, Golnik KC. Optic Neuropathy As the Initial Presenting Sign of N-methyl-d-aspartate (NMDA) Encephalitis. Neuroophthalmology. 2017 Jan 11;41(2):90-93. doi: 10.1080/01658107.2016.1262431. eCollection 2017 Apr. PubMed PMID: 28348631; PubMed Central PMCID: PMC5354102.
Stankowska DL, Mueller BH 2nd, Oku H, Ikeda T, Dibas A. Neuroprotective effects of inhibitors of Acid-Sensing ion channels (ASICs) in optic nerve crush model in rodents. Curr Eye Res. 2018 Jan;43(1):84-95. PubMed PMID: 29111855.
Mueller B. From Neurology to Glaucoma. Glaucoma Today. 2017 May/June.
Ellis DZ, Li L, Park Y, He S, Mueller B, Yorio T. Sigma-1 Receptor Regulates Mitochondrial Function in Glucose- and Oxygen-Deprived Retinal Ganglion Cells. Invest Ophthalmol Vis Sci. 2017 May 1;58(5):2755-2764. doi: 10.1167/iovs.16-19199. PubMed PMID: 28549090.
Blackburn R, Mueller BH, Ramasubramanian A. A Stepwise Approach to the Ocular Manifestations of Graft-vs-Host Disease. Eyenet Magazine. 2017 May 35-37.
Mugavin M, Mueller BH 2nd, Desai M, Golnik KC. Optic Neuropathy As the Initial Presenting Sign of N-methyl-d-aspartate (NMDA) Encephalitis. Neuroophthalmology. 2017 Jan 11;41(2):90-93. doi: 10.1080/01658107.2016.1262431. eCollection 2017 Apr. PubMed PMID: 28348631; PubMed Central PMCID: PMC5354102.
Park YH, Mueller BH 2nd, McGrady NR, Ma HY, Yorio T. AMPA receptor desensitization is the determinant of AMPA receptor mediated excitotoxicity in purified retinal ganglion cells. Exp Eye Res. 2015 Mar;132:136-50. doi: 10.1016/j.exer.2015.01.026. Epub 2015 Jan 30. PubMed PMID: 25643624.
Stankowska DL, Minton AZ, Rutledge MA, Mueller BH 2nd, Phatak NR, He S, Ma HY, Forster MJ, Yorio T, Krishnamoorthy RR. Neuroprotective effects of transcription factor brn3b in an ocular hypertension rat model of glaucoma. Invest Ophthalmol Vis Sci. 2015 Jan 13;56(2):893-907. doi: 10.1167/iovs.14-15008. PubMed PMID: 25587060; PubMed Central PMCID: PMC4321399.
Mueller BH 2nd, Park Y, Ma HY, Dibas A, Ellis DZ, Clark AF, Yorio T. Sigma-1 receptor stimulation protects retinal ganglion cells from ischemia-like insult through the activation of extracellular-signal-regulated kinases 1/2. Exp Eye Res. 2014 Nov;128:156-69. doi: 10.1016/j.exer.2014.10.007. Epub 2014 Oct 8. PubMed PMID: 25305575.
Mueller BH 2nd, Park Y, Daudt DR 3rd, Ma HY, Akopova I, Stankowska DL, ClarkAF, Yorio T. Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells. Exp Eye Res. 2013 Feb;107:21-31. doi: 10.1016/j.exer.2012.11.002. PubMed PMID: 23183135.
Minton AZ, Phatak NR, Stankowska DL, He S, Ma HY, Mueller BH, Jiang M, Luedtke R, Yang S, Brownlee C, Krishnamoorthy RR. Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma. PLoS One. 2012;7(8):e43199. doi: 10.1371/journal.pone.0043199. PubMed PMID: 22916224; PubMed Central PMCID: PMC3423444.
Das HK, Tchedre K, Mueller B. Repression of transcription of presenilin-1 inhibits γ-secretase independent ER Ca²⁺ leak that is impaired by FAD mutations. J Neurochem. 2012 Aug;122(3):487-500. doi: 10.1111/j.1471-4159.2012.07794.x. PubMed PMID: 22607268.
Daudt DR 3rd, Mueller B, Park YH, Wen Y, Yorio T. Methylene blue protects primary rat retinal ganglion cells from cellular senescence. Invest Ophthalmol Vis Sci. 2012 Jul 10;53(8):4657-67. doi: 10.1167/iovs.12-9734. PubMed PMID:22661471.
Park Y, Ellis D, Mueller B, Stankowska D, Yorio T. Principles of Ocular Pharmacology. Handb Exp Pharmacol. 2017;242:3-30. doi: 10.1007/164_2016_25. PubMed PMID: 27730396.
Brett H. Mueller II, Dorota L. Stankowska and Raghu R. Krishnamoorthy (2011). Neuroprotection in Glaucoma, Glaucoma – Basic and Clinical Concepts, Dr Shimon Rumelt (Ed.), ISBN: 978-953-307-591-4, InTech, DOI: 10.5772/18465. Available from: https://www.intechopen.com/books/glaucoma-basic-and-clinical-concepts/neuroprotection-in-glaucoma
Mueller B, Nikapoor N, Rebenitsch L, Parkhurst G, Kugler L, Zhu D, McKey J, Venkateswaran N, Saenz B, Schoenberg E, Brenner J, Goel S, Bafna S. LASIK Patient Motivators. ASCRS, Washington D.C., April 2022
Mueller B, Parkhurst G, Welburn K, Saenz B. Prospective Analysis of PanOptix in Patients with Prior Myopic Laser Vision Correction. ASCRS, Washington D.C., April 2022
Mueller B. Depth of Focus and Precision with the Light Adjustable Lens. ASCRS, Washington DC. April 2022
Mueller B, Saenz B, Parkhurst G, Sandberg K, Welburn K. Prospective Analysis to Assess Placing a Panoptix Trifocal LENS in Patients Who Have Had Prior Myopic Laser Vision Correction Surgery. ASCRS, Las Vegas, NV. 26 July 2021
Parkhurst G, Mueller B. Effectiveness of Femtosecond Laser Assisted Cataract Surgery Astigmatism Correction with Iris Registration for Low Power Toric IOL Alignment. ASCRS, Las Vegas, NV. 26 July 2021
Mueller B, Parkhurst G. Utilizing ArcScan to Size the STAAR Visian ICL. ASCRS, Las Vegas, NV. 25 July 2021
Mueller B. AcrySof IQ PanOptix Trifocal IOL: Experience the Trifocal Trifecta. ASCRS, Las Vegas, NV. 25 July 2021
Mueller B. Posterior Polar Cataract – A posterior capsular tear from one side of the lens equator to the other. AECOS Summer Meeting, July 15-18, 2021
Mueller BH, Saenz B, Abraham N, Cavazos C, Parkhurst G. Toric Implantable Collamer Lenses: Early United States Experience. ASCRS Annual Meeting, May 16-17, 2020.
Uncertainties in Fellowship and Beyond | Priyanka Sood, MD; Neel Desai, MD; Lorraine Provencher, MD; Joshua Frenkel, MD, MPH; Brett Mueller, D.O., Ph.D. Millenial Live, Louisville, KY, September 2019
Dibas A, Stankowska D, Mueller B, Hidehiro O, Yorio T. Neuroprotective Effects of Inhibitors of Acid-Sensing Ion Channels (ASIC) in Optic Nerve Crush Model in Rodents. ARVO Annual Meeting, Abstract Number 3405. Baltimore, MD. May 2017
Mueller BH, Park Y, Ma H, Yorio T. Sigma-1 Receptor Stimulation Protects Purified RGCs from Ischemic Insult through the Phosphorylation of Extracellular Signal Regulated Kinase 1/2. ARVO Annual Meeting, Abstract Number 3699. Seattle, WA. May 2013
Mueller BH, Dibas A, Park Y, Ma H, Oku H, Fukuhara M, Kurimoto T, Ikeda T, Clark AF, Yorio T. Prolonged NMDA Treatment Induces Neuroprotective Pathways in Primary Retinal Ganglion Cells through Phosphorylation of cAMP Response Element-Binding Protein (CREB). XX Biennial Meeting of the International Society for Eye Research (ISER). Abstract number A-412-0006-00719. Berlin, Germany. July 21-25, 2012
Mueller B, Raj R; Bhola R. Wind Instruments: A Cause of Chronic Elevation of Intraocular Pressure in a Pediatric Population. ARVO Annual Meeting, Abstract Number 5333 – B0430. Baltimore, MD. May 2017
Godwin K, Mueller BH, Soltau JB, Mohay-Ambrus J, DeMarco P. Modeling the Pattern Electroretinogram in Patients with Primary Open-Angle Glaucoma. ARVO Annual Meeting, Abstract Number 4888 – B0277. Baltimore, MD. May 2017
Mueller BH, Park Y, Ma HY, Yorio, T. Prolonged NMDA Stimulation Induces Neuroprotective Pathways and Enhances Survivability of Primary Retinal Ganglion Cells. ARVO Annual Meeting, Session Number 242. Orlando, FL. May 2014
Park Y, Mueller BH, McGrady N, Dibas, A.; Yorio, T. Retinal Ganglion Cells Are Resistant to AMPA Receptor Mediated Excitotoxicity. ARVO. Orlando, FL. May 2014
Park Y, Mueller B, Ma HY, Yorio T. Stimulation of the AMPA Receptor in Retinal Ganglion Cells Increases Phosphorylation of CREB. ARVO Annual Meeting. Seattle, WA. May 2013
Mueller B, Park Y, Ma H, Yorio T. Inhibition of NMDA Induced Calcium Ion Influx in Retinal Ganglion Cells through NMDA Stimulation. ARVO Annual Meeting, Session Number 478. Fort Lauderdale, FL. May 2012.
Minton A, Phatak N, Ma H, Stankowska D, He S, Mueller B, Krishnamoorthy R. Endothelin B Receptors Contribute to Neurodegeneration in a Rodent Model of Glaucoma. ARVO Annual Meeting, Session Number 479. Fort Lauderdale, FL. May 2012.
Minton A, Phatak N, Mueller B, Ma H, Jian M, He S, Krishnamoorthy R. Neurodegenerative Effects of Endothelin B Receptor in a Rodent Model of Glaucoma. ARVO Annual Meeting, Session Number 312. Fort Lauderdale, FL. May 2011.
Mueller B, Krishnamoorthy R, Daudt D, Ma H, Yorio T. Interaction of Sigma-1 Receptors with Voltage Gated Calcium Channels Attenuates Calcium Response in Primary Retinal Ganglion Cells. ARVO Annual Meeting, Session Number 312. Fort Lauderdale, FL. May 2011.
Yorio T, Daudt D, Mueller B. Effects of Sigma-1 Receptors on Mitochondrial Fusion in Retinal Ganglion Cells. ARVO Annual Meeting, Session Number 456. Fort Lauderdale, FL. May 2011.
Mueller B, Krishnamoorthy R, Yorio T. Sigma-1 Receptor Expression in Retinal Ganglion Cells after Ocular Hypertension in Rats. ARVO Annual Meeting, Session Number 520. Fort Lauderdale, FL. May 2010.
Krishnamoorthy R, Ma H, Mueller B. Increased Endothelin B Receptor Expression in Retinal Ganglion Cells after Ocular Hypertension in Rats. ARVO Annual Meeting, Session Number 520. Fort Lauderdale, FL. May 2010.
Mueller B, Page R. Medicare 2005 Demonstration Project: Patient Reporting of Nausea Symptoms and its Impact on Improving Quality of Patient Care. Texas Society of Medical Oncology Annual Meeting. Houston, TX. October 2007.
Fletcher S, Mueller B. Neurosurgical Management of Children with Persistent Vomiting or Syncope as the Sole Finding in Chiari Syndrome. The American College of Osteopathic Surgeons National Meeting. San Francisco, CA. October 2007.
Mueller B, Page R. Medicare 2005 Demonstration Project: Patient Reporting of Nausea Symptoms and its Impact on Improving Quality of Patient Care. American Society for Cancer Oncology Conference. Chicago, IL. ASCO 2007 Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 6615.
Osmulski P, Mueller B, Gaczynska M. The Ubiquitin Family. Summer FASEB Research Conference. Saxton River, VT. July 2006.
Osmulski P, Mueller B, Tan X, Gaczynska M. Proteases-Related Molecular Signature of Breast Cancer. Era of Hope DOD Breast Cancer Research Program Meeting. Philadelphia, PA. June 2006.
Mueller B, Osmulski P, Gaczynska M. Proteasome-Related Molecular Signature of Breast Cancer. Annual Retreat of San Antonio Cancer Institute/Genomic Integrity and Carcinogenesis Program. San Antonio, TX. May 2005.
Mueller B. Mentoring Session with Brett H. Mueller II, D.O., Ph.D. Young MD Connect. April 8, 2021
Hura A, Mueller B, & Venkateswaran N. Building a Patient Base in Refractive Surgery.. Eyes on Eyecare. August 9, 2023
Blake Williamson, MD, MPH; Brett Mueller, DO, PhD. Private Practice Fellowships. Young MD Connect Live. April 5, 2023
Mueller B, Zhu D, and Shamie N. Getting Comfortable with Advanced Presbyopia-Correcting Technologies. Presbyopia Unlocked. Eyetube, BMC Today. 4/29/2020
Saenz B and Mueller B. Eye Health and Surgical Outcomes, Treating Keratoconus, Specializing in Ocular Aesthetics. Eyetube, The MODPOD. Episode 11. 2/25/2020.
Principal Investigator: Post-Approval Study of the Vivity EDOF Lens in Patients Who Have Had Post Refractive Hyperopic Laser Vision Correction Surgery.
Principal Investigator: Post-Approval Study of the PanOptix Trifocal Lens in Patients Who Have Had Post Refractive Myopic Laser Vision Correction Surgery.
Sub-Investigator: A Prospective, Multicenter, Non-Randomized Clinical Trial Designed to Evaluate the Safety and Effectiveness of the ELIOS System to Reduce Intraocular Pressure in Patients with Primary Open-Angle Glaucoma Undergoing Cataract Surgery
Sub-Investigator: A Prospective, Multicenter, Randomized, Active-Controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction.
Sub-Investigator: Clinical Evaluation of the Vision Performance of Tecnis Eyhance™ Intraocular Lenses with Tecnis Simplicity™ as Compared to Tecnis® 1-Piece Intraocular Lenses.
Sub-Investigator: A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the MEL90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism.
Sub-Investigator: A Randomized, Placebo- Controlled, Double-Masked, Multicenter, Dosing-Range Study to Evaluate the Safety, and Efficacy of UNR844 in Subjects with Presbyopia
Sub-Investigator: Prospective, Controlled, Randomized Bilateral and Non-Randomized Unilateral, Multicenter Clinical Investigation of the SC9 Extended Depth of Focus Intraocular Lens compared with Control (Bausch & Lomb Monofocal LI61SE Intraocular Lens)
Sub-Investigator: FDA Clinical Trial Investigating the EVO/EVO+ Visian Implantable Collamer Lens (ICL)
Sub-Investigator: Yukon Study, Post-Market Evaluation of Surgeon Feedback of TECNIS Toric II Intraocular Lens (IOL). NXGT-201-TTL2. 2020
Sub-Investigator: Post-Approval Study of the TECNIS Symfony Toric Lenses. 2019.
Sub-Investigator: A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of AGN-190584 in Participants with Presbyopia. 2018.
Sub-Investigator: A Prospective Clinical Trial to Evaluate the Safety and Effectiveness of Model SC9 Posterior Chamber Silicone Intraocular Lens for Primary Implantation in the Capsular Bag of the Eye for Visual Correction of Aphakia Secondary to Removal of a Cataractous Lens in Adult Patients With or Without Presbyopia. The IOL is Intended to Improve Near and Intermediate Vision as Compared to a Legally Marketed IOL. 2018.
Sub-Investigator: Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5%. San Antonio, Texas. 2018.
Sub-Investigator: iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study. San Antonio, Texas. 2019
Family Focused
The only thing that Dr. Mueller loves more than LASIK and Cataract eye surgery is his family. His wife, Deanna, is a Physician Assistant, and you will likely see her beautiful presences and smile as you come into the office. They are proud parents of 3 beautiful kids: Brett III, Daniel, and Autumn.
A lover of the outdoors, Dr. Mueller spends his time away from work running, camping, and engaging in outdoor activities. Mueller Vision prides itself on an environment that mirrors the family values of Dr. Mueller. They eagerly anticipate providing you with care that feels as though you’re among family. We look forward to seeing you soon!!!
